Abstract
The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted from a man to a woman during vaginal intercourse. Several factors, including vaginal intercourse at an early age or with multiple sex partners, place women at increased risk for infection with HPV. It is important for physicians to be aware of these risk factors and to screen for them in all of their female patients. It is also important for physicians to be familiar with the new HPV vaccinations that are becoming available, such as Gardasil, which in June 2006 became the first vaccine approved by the US Food and Drug Administration to protect patients against cervical cancer. The widespread use of routine HPV screening and cervical cancer vaccines can be expected to decrease the incidence of new HPV infection and cervical cancer worldwide.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 65-70 |
| Number of pages | 6 |
| Journal | Journal of the American Osteopathic Association |
| Volume | 108 |
| Issue number | 2 |
| State | Published - Feb 1 2008 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Reducing patient risk for human papillomavirus infection and cervical cancer. / Herbert, Jennifer; Coffin, Janis Strickland.
In: Journal of the American Osteopathic Association, Vol. 108, No. 2, 01.02.2008, p. 65-70.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Reducing patient risk for human papillomavirus infection and cervical cancer
AU - Herbert, Jennifer
AU - Coffin, Janis Strickland
PY - 2008/2/1
Y1 - 2008/2/1
N2 - The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted from a man to a woman during vaginal intercourse. Several factors, including vaginal intercourse at an early age or with multiple sex partners, place women at increased risk for infection with HPV. It is important for physicians to be aware of these risk factors and to screen for them in all of their female patients. It is also important for physicians to be familiar with the new HPV vaccinations that are becoming available, such as Gardasil, which in June 2006 became the first vaccine approved by the US Food and Drug Administration to protect patients against cervical cancer. The widespread use of routine HPV screening and cervical cancer vaccines can be expected to decrease the incidence of new HPV infection and cervical cancer worldwide.
AB - The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted from a man to a woman during vaginal intercourse. Several factors, including vaginal intercourse at an early age or with multiple sex partners, place women at increased risk for infection with HPV. It is important for physicians to be aware of these risk factors and to screen for them in all of their female patients. It is also important for physicians to be familiar with the new HPV vaccinations that are becoming available, such as Gardasil, which in June 2006 became the first vaccine approved by the US Food and Drug Administration to protect patients against cervical cancer. The widespread use of routine HPV screening and cervical cancer vaccines can be expected to decrease the incidence of new HPV infection and cervical cancer worldwide.
UR - http://www.scopus.com/inward/record.url?scp=40349102081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40349102081&partnerID=8YFLogxK
M3 - Article
C2 - 18303060
AN - SCOPUS:40349102081
VL - 108
SP - 65
EP - 70
JO - The Journal of the American Osteopathic Association
JF - The Journal of the American Osteopathic Association
SN - 0098-6151
IS - 2
ER -